CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified Cells

This publication has 16 references indexed in Scilit:

• Reversible Expression of CD34 by Murine Hematopoietic Stem Cells
  Blood, 1999
• Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS Device
  Journal of Hematotherapy, 1999
• Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
  Nature Medicine, 1998
• Impact of a new generation of gene transfer markers on gene therapy
  Gene Therapy, 1998
• Selective Immunoaffinity-Based Enrichment of CD34⁺Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) Gene
  Human Gene Therapy, 1997
• HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
  Science, 1997
• Transduction of Human Hematopoietic Cells and Cell Lines Using a Retroviral Vector Containing a Modified Murine CD4 Reporter Gene
  Human Gene Therapy, 1997
• Measuring gene–transfer efficiency
  Nature Medicine, 1996
• Cell–surface markers for assessing gene transfer into human hematopoietic cells
  Nature Medicine, 1996
• CD34: structure, biology, and clinical utility [see comments]
  Blood, 1996